Abstract
It is widely accepted that immunological infertility is one of the major causes of infertility in humans. On average, infertility occurs in one in every five couples of reproductive age and about 10–20 % of them is unexplained. A subset of infertile patients has been found to possess antisperm antibodies (ASA) in semen, blood, cervical mucus, or follicular fluid. ASA may affect sperm concentration and survival, limit sperm transport and motility and therefore the passage through the female reproductive tract specifically the cervix, inhibit sperm oocyte binding, prevent capacitation and acrosome reaction, affect embryo development and implantation, and has been proposed to lead to spontaneous miscarriage. Several strategies are used to counteract the deleterious effects of ASA-mediated infertility. The basic approaches for the treatment of men with ASA are as follows: minimizing exposure to sperm antigen like the use of condoms, decrease ASA production by immunosuppression with prednisone, removal of sperm bound ASA by a combination of laboratory techniques and sperm washing, and finally the most successful of all, the assisted reproductive technologies (ART).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mathur S, Rosenlund C, Carlton M, et al. Studies on sperm survival and motility in the presence of cytotoxic sperm antibodies. Am J Reprod Immunol Microbiol. 1988;17:41–7.
Check JH, Adelson HG, Bollendorf A. Effect of antisperm antibodies on computerized semen analysis. Arch Androl. 1991;27:61–3.
Upadhyaya M, Hibbard BM, Walker SM. Antisperm antibodies and male infertility. Br J Urol. 1984;56:531–6.
Practice Committee of American Society for Reproductive M. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2012;98:294–301.
Jager S, Kremer J, van Slochteren-Draaisma T. A simple method of screening for antisperm antibodies in the human male. Detection of spermatozoal surface IgG with the direct mixed antiglobulin reaction carried out on untreated fresh human semen. Int J Fertil. 1978;23:12–21.
Haas GG, Jr., Schreiber AD, Blasco L. The incidence of sperm-associated immunoglobulin and C3, the third component of complement, in infertile men. Fertil Steril. 1983;39:542–7.
D’Cruz OJ, Haas GG, Jr., Wang BL, DeBault LE. Activation of human complement by IgG antisperm antibody and the demonstration of C3 and C5b-9-mediated immune injury to human sperm. J Immunol. 1991;146:611–20.
Price RJ, Boettcher B. The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. Fertil Steril. 1979;32:61–6.
De Almeida M, Soumah A, Jouannet P. Incidence of sperm-associated immunoglobulins in infertile men with suspected autoimmunity to sperm. Int J Androl. 1986;9:321–30.
Busacca M, Fusi F, Brigante C, Doldi N, Smid M, Vigano P. Evaluation of antisperm antibodies in infertile couples with immunobead test: prevalence and prognostic value. Acta Eur Fertil. 1989;20:77–82.
Menge AC, Beitner O. Interrelationships among semen characteristics, antisperm antibodies, and cervical mucus penetration assays in infertile human couples. Fertil Steril. 1989;51:486–92.
Mortimer D, Pandya IJ, Sawers RS. Relationship between human sperm motility characteristics and sperm penetration into human cervical mucus in vitro. J Reprod Fertil. 1986;78:93–102.
Kremer J, Jager S. Characteristics of anti-spermatozoal antibodies responsible for the shaking phenomenon with special regard to immunoglobulin class and antigen-reactive sites. Int J Androl. 1980;3:143–52.
Witkin SS, Viti D, David SS, Stangel J, Rosenwaks Z. Relation between antisperm antibodies and the rate of fertilization of human oocytes in vitro. J Assist Reprod Genet. 1992;9:9–13.
Wang C, Baker HW, Jennings MG, Burger HG, Lutjen P. Interaction between human cervical mucus and sperm surface antibodies. Fertil Steril. 1985;44:484–8.
Hall JL, Engel D, Naz RK. Significance of antibodies against human sperm FA-1 antigen in immunoinfertility. Arch Androl. 1994;32:25–30.
Bronson RA, Cooper GW, Rosenfeld DL. Sperm-specific isoantibodies and autoantibodies inhibit the binding of human sperm to the human zona pellucida. Fertil Steril. 1982;38:724–9.
Mahony MC, Blackmore PF, Bronson RA, Alexander NJ. Inhibition of human sperm-zona pellucida tight binding in the presence of antisperm antibody positive polyclonal patient sera. J Reprod Immunol. 1991;19:287–301.
Naz RK, Brazil C, Overstreet JW. Effects of antibodies to sperm surface fertilization antigen-1 on human sperm-zona pellucida interaction. Fertil Steril. 1992;57:1304–10.
Abdel-Latif A, Mathur S, Rust PF, Fredericks CM, Abdel-Aal H, Williamson HO. Cytotoxic sperm antibodies inhibit sperm penetration of zona-free hamster eggs. Fertil Steril. 1986;45:542–9.
Shibahara H, Shigeta M, Inoue M, et al. Diversity of the blocking effects of antisperm antibodies on fertilization in human and mouse. Hum Reprod. 1996;11:2595–9.
Francavilla F, Romano R, Santucci R, Marrone V, Properzi G, Ruvolo G. Occurrence of the interference of sperm-associated antibodies on sperm fertilizing ability as evaluated by the sperm-zona pellucida binding test and by the TEST-yolk buffer enhanced sperm penetration assay. Am J Reprod Immunol. 1997;37:267–74.
Tian X, Zhang L, Wu Y, Yang C, Liu P. Relationship between serum antisperm antibodies and anticardiolipin antibodies and clinical pregnancy outcome in an in vitro fertilization and embryo transfer program. Chin Med J (Engl). 1999;112:34–6.
Lahteenmaki A, Reima I, Hovatta O. Treatment of severe male immunological infertility by intracytoplasmic sperm injection. Hum Reprod. 1995;10:2824–8.
Wolff H, Schill WB. Antisperm antibodies in infertile and homosexual men: relationship to serologic and clinical findings. Fertil Steril. 1985;44:673–7.
Greskovich F, Mathur S, Nyberg LM, Jr., Collins BS. Effect of early antibiotic treatment on the formation of sperm antibodies in experimentally induced epididymitis. Arch Androl. 1993;30:183–91.
Greentree LB. Antisperm antibodies in infertility: the role of condom therapy. Fertil Steril. 1982;37:451–2.
Kremer J, Jager S, Kuiken J. Treatment of infertility caused by antisperm antibodies. Int J Fertil. 1978;23:270–6.
Rosse WF. Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. J Clin Invest. 1971;50:734–43.
Turek PJ, Lipshultz LI. Immunologic infertility. Urol Clin North Am. 1994;21:447–68.
Hendry WF, Treehuba K, Hughes L, Stedronska J, Parslow JM, Wass JA, Besser GM. Cyclic prednisolone therapy for male infertility associated with autoantibodies to spermatozoa. Fertil Steril. 1986;45(2):249–54.
Haas GG, Jr., Manganiello P. A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-associated immunoglobulins. Fertil Steril. 1987;47:295–301.
De Almeida M, Feneux D, Rigaud C, Jouannet P. Steroid therapy for male infertility associated with antisperm antibodies: results of a small randomized clinical trial. Int J Androl. 1985;8:111–7.
Hendry WF, Hughes L, Scammell G, Pryor JP, Hargreave TB. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet. 1990;335:85–8.
Sharma KK, Barratt CL, Pearson MJ, Cooke ID. Oral steroid therapy for subfertile males with antisperm antibodies in the semen: prediction of the responders. Hum Reprod. 1995;10:103–9.
Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis. 2009;68:1833–8.
Sakamoto Y, Matsumoto T, Kumazawa J. Cell-mediated autoimmune response to testis induced by bilateral testicular injury can be suppressed by cyclosporin A. J Urol. 1998;159:1735–40.
Bouloux PM, Wass JA, Parslow JM, Hendry WF, Besser GM. Effect of cyclosporin A in male autoimmune infertility. Fertil Steril. 1986;46:81–5.
Halim A, Antoniou D, Leedham PW, Blandy JP, Tresidder GC. Investigation and treatment of the infertile male. Proc R Soc Med. 1973;66:373–8.
Bronson R. Immunity in sperm and in vitro fertilization. J In Vitro Fert Embryo Transf. 1987;4:195–7.
Elder KT, Wick KL, Edwards RG. Seminal plasma anti-sperm antibodies and IVF: the effect of semen sample collection into 50 % serum. Hum Reprod. 1990;5:179–84.
Lenzi A, Gandini L, Claroni F, Lombardo F, Morrone S, Dondero F. Immunological usefulness of semen manipulation for artificial insemination homologous (AIH) in subjects with antisperm antibodies bound to sperm surface. Andrologia. 1988;20:314–21.
Windt ML, Menkveld R, Kruger TF, van der Merwe JP, Lombard CJ. Effect of rapid dilution of semen on sperm-bound autoantibodies. Arch Androl. 1989;22:227–31.
Naz RK, Bhargava KK. Antibodies to sperm surface fertilization antigen (FA-1): their specificities and site of interaction with sperm in male genital tract. Mol Reprod Dev 1990;26:175–83.
Gould JE, Brazil CK, Overstreet JW. Sperm-immunobead binding decreases with in vitro incubation. Fertil Steril. 1994;62:167–71.
Grundy CE, Robinson J, Guthrie KA, Gordon AG, Hay DM. Establishment of pregnancy after removal of sperm antibodies in vitro. BMJ. 1992;304:292–3.
Verheyen G, Tournaye H, Laurier K, Devroey P, Van Steirteghem A. Auto-controlled study on in-vitro fertilization performance with ‘antibody-free’ spermatozoa selected by immunobead adsorption from semen of patients with anti-sperm antibodies. Hum Reprod. 1994;9:1119–26.
Junk SM, Matson PL, O'Halloran F, Yovich JL. Use of immunobeads to detect human antispermatozoal antibodies. Clin Reprod Fertil. 1986;4:199–206.
Hanson FM, Rock J. Artificial insemination with husband’s sperm. Fertil Steril. 1951;2:162–74.
Shulman S, Harlin B, Davis P, Reyniak JV. Immune infertility and new approaches to treatment. Fertil Steril. 1978;29:309–13.
Adeghe AJ. Effect of washing on sperm surface autoantibodies. Br J Urol. 1987;60:360–3.
Shekarriz M, DeWire DM, Thomas AJ, Jr., Agarwal A. A method of human semen centrifugation to minimize the iatrogenic sperm injuries caused by reactive oxygen species. Eur Urol. 1995;28:31–5.
Bollendorf A, Check JH, Katsoff D, Fedele A. The use of chymotrypsin/galactose to treat spermatozoa bound with anti-sperm antibodies prior to intra-uterine insemination. Hum Reprod. 1994;9:484–8.
Bronson RA, Cooper GW, Rosenfeld DL, Gilbert JV, Plaut AG. The effect of an IgA1 protease on immunoglobulins bound to the sperm surface and sperm cervical mucus penetrating ability. Fertil Steril. 1987;47:985–91.
Kutteh WH, Kilian M, Ermel LD, Byrd EW, Mestecky J. Antisperm antibodies (ASAs) in infertile males: subclass distribution of IgA antibodies and the effect of an IgA1 protease on sperm-bound antibodies. Am J Reprod Immunol. 1994;31:77–83.
Pattinson HA, Mortimer D, Curtis EF, Leader A, Taylor PJ. Treatment of spermagglutination with proteolytic enzymes. I. Sperm motility, vitality, longevity and successful disagglutination. Hum Reprod. 1990;5:167–73.
Pattinson HA, Mortimer D, Taylor PJ. Treatment of spermagglutination with proteolytic enzymes. II. Sperm function after enzymatic disagglutination. Hum Reprod. 1990;5:174–8.
Kiser GC, Alexander NJ, Fuchs EF, Fulgham DL. In vitro immune absorption of antisperm antibodies with immunobead-rise, immunomagnetic, and immunocolumn separation techniques. Fertil Steril. 1987;47:466–74.
Clarke GN, Hsieh C, Koh SH, Cauchi MN. Sperm antibodies, immunoglobulins, and complement in human follicular fluid. Am J Reprod Immunol. 1984;5:179–81.
Bronson RA. Antisperm antibodies: a critical evaluation and clinical guidelines. J Reprod Immunol. 1999;45:159–83.
Check JH, Bollendorf A, Katsoff D, Kozak J. The frequency of antisperm antibodies in the cervical mucus of women with poor postcoital tests and their effect on pregnancy rates. Am J Reprod Immunol. 1994;32:38–42.
Gregoriou O, Vitoratos N, Papadias C, Konidaris S, Maragudakis A, Zourlas PA. Intrauterine insemination as a treatment of infertility in women with antisperm antibodies. Int J Gynaecol Obstet. 1991;35:151–6.
Margalloth EJ, Sauter E, Bronson RA, Rosenfeld DL, Scholl GM, Cooper GW. Intrauterine insemination as treatment for antisperm antibodies in the female. Fertil Steril. 1988;50:441–6.
Ulstein M. Fertility of husbands at homologous insemination. Acta Obstet Gynecol Scand. 1973;52:5–8.
Galle PC, McRae MA, Colliver JA, Alexander JS. Sperm washing and intrauterine insemination for cervical factor, oligospermia, immunologic infertility and unexplained infertility. J Reprod Med. 1990;35:116–22.
Francavilla F, Romano R, Santucci R, Marrone V, Corrao G. Failure of intrauterine insemination in male immunological infertility in cases in which all spermatozoa are antibody-coated. Fertil Steril. 1992;58:587–92.
Check JH, Bollendorf A. Effect of antisperm antibodies on postcoital results and effect of intrauterine insemination on pregnancy outcome. Arch Androl. 1992;28:25–31.
Agarwal A. Treatment of immunological infertility by sperm washing and intrauterine insemination. Arch Androl. 1992;29:207–13.
Junk SM, Matson PL, Yovich JM, Bootsma B, Yovich JL. The fertilization of human oocytes by spermatozoa from men with antispermatozoal antibodies in semen. J In Vitro Fert Embryo Transf. 1986;3:350–2.
Ford WC, Williams KM, McLaughlin EA, Harrison S, Ray B, Hull MG. The indirect immunobead test for seminal antisperm antibodies and fertilization rates at in-vitro fertilization. Hum Reprod. 1996;11:1418–22.
Acosta AA, Van Der Merwe JP, Doncel G, Kruger TF, Sayilgan A, Franken DR, Kolm P. Fertilization efficiency of morphologically abnormal spermatozoa in assisted reproduction is further impaired by antisperm antibodies on the male partner’s sperm. Fertil Steril. 1994;62:826–833.
Vujisic S, Lepej SZ, Jerkovic L, Emedi I, Sokolic B. Antisperm antibodies in semen, sera and follicular fluids of infertile patients: relation to reproductive outcome after in vitro fertilization. Am J Reprod Immunol. 2005;54:13–20.
Clarke GN. Association between sperm autoantibodies and enhanced embryo implantation rates during in vitro fertilization. Fertil Steril. 2006;86:753–4.
Clarke GN, Lopata A, McBain JC, Baker HW, Johnston WI. Effect of sperm antibodies in males on human in vitro fertilization (IVF). Am J Reprod Immunol Microbiol. 1985;8:62–6.
Lahteenmaki A. In-vitro fertilization in the presence of antisperm antibodies detected by the mixed antiglobulin reaction (MAR) and the tray agglutination test (TAT). Hum Reprod. 1993;8:84–8.
De Almeida M, Herry M, Testart J, Belaisch-Allart J, Frydman R, Jouannet P. In-vitro fertilization results from 13 women with anti-sperm antibodies. Hum Reprod. 1987;2:599–602.
Zini A, Lefebvre J, Kornitzer G, et al. Anti-sperm antibody levels are not related to fertilization or pregnancy rates after IVF or IVF/ICSI. J Reprod Immunol. 2011;88:80–4.
Yeh WR, Acosta AA, Seltman HJ, Doncel G. Impact of immunoglobulin isotype and sperm surface location of antisperm antibodies on fertilization in vitro in the human. Fertil Steril. 1995;63:1287–92.
Mardesic T, Ulcova-Gallova Z, Huttelova R, et al. The influence of different types of antibodies on in vitro fertilization results. Am J Reprod Immunol. 2000;43:1–5.
Clarke GN, Bourne H, Baker HW. Intracytoplasmic sperm injection for treating infertility associated with sperm autoimmunity. Fertil Steril. 1997;68:112–7
Check ML, Check JH, Katsoff D, Summers-Chase D. ICSI as an effective therapy for male factor with antisperm antibodies. Arch Androl. 2000;45:125–30.
Esteves SC, Schneider DT, Verza S Jr. Influence of antisperm antibodies in the semen on intracytoplasmic sperm injection outcome. Int Braz J Urol. 2007;33:795–802.
Nagy ZP, Verheyen G, Liu J, et al. Results of 55 intracytoplasmic sperm injection cycles in the treatment of male-immunological infertility. Hum Reprod. 1995;10:1775–80.
Ahmad K, Naz RK. Effects of human antisperm antibodies on development of preimplantation embryos. Arch Androl. 1992;29:9–20.
Naz RK. Involvement of fertilization antigen (FA-1) in involuntary immunoinfertility in humans. J Clin Invest. 1987;80:1375–83.
Menge AC, Christman GM, Ohl DA, Naz RK. Fertilization antigen-1 removes antisperm autoantibodies from spermatozoa of infertile men and results in increased rates of acrosome reaction. Fertil Steril. 1999;71:256–60.
Steures P, van der Steeg JW, Mol BW, et al. Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril. 2004;82:45–51.
van Weert JM, Repping S, van der Steeg JW, Steures P, van der Veen F, Mol BW. IUI in male subfertility: are we able to select the proper patients? Reprod Biomed Online 2005;11:624–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Paduch, D., Dabaja, A. (2015). Treatment and Prognosis of Immunological Factors in Unexplained Male Infertility. In: Schattman, G., Esteves, S., Agarwal, A. (eds) Unexplained Infertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2140-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2140-9_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2139-3
Online ISBN: 978-1-4939-2140-9
eBook Packages: MedicineMedicine (R0)